TrialBMC medicine2026

Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian cancer: a phase 3, double-blind, parallel group, randomized controlled pilot study.

Ga Won Yim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.